Literature DB >> 17106547

Clinical presentations and laboratory findings in suspected cases of dengue virus.

Ali K Ageep1, Aml A Malik, Mubarak S Elkarsani.   

Abstract

OBJECTIVE: To study the clinical presentations and laboratory findings of patients presented with fever in a Hospital in Portsudan, Sudan and to detect dengue virus antibodies in their blood.
METHODS: This study was carried in Almwani Hospital during the period from April to July 2005. Eighty-four patients were included in this hospital-based study. All of them had fever. Their blood films, Widal tests for typhoid, stools and urine investigations were normal. The clinical data were collected using questionnaires. Two samples of blood were taken. One was for general hematological investigation (white blood cell and platelets count), while serum was taken from the other sample for serological detection of the dengue virus antibodies using the enzyme-linked immunosorbent assay (ELISA) technique.
RESULTS: The fever was associated with vomiting (22 patients) and abdominal pain (44 patients). In 93% of the cases bleeding (epistaxes, purpura, malena, hematemesis, and others) occurred. Routine laboratory findings were leucopenia (90% of the cases) and thrombocytopenia (88% of the cases). The diagnosis was confirmed by ELISA detection of dengue virus immunoglobulin M antibodies (in 88% of the patient's sera).
CONCLUSION: In endemic areas with mosquitoes such as Aedes aegypti, infection with dengue virus should highly be suspected in patients presented with fever. The ELISA or rapid tests for detection of the viral antibodies should be added to the routine investigations to any patient with complain of fever with no obvious cause. Surveillance program and mosquito control measures should be activated in Portsudan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106547

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

Review 1.  Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.

Authors:  James A Potts; Alan L Rothman
Journal:  Trop Med Int Health       Date:  2008-09-16       Impact factor: 2.622

2.  Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan.

Authors:  Ishag Adam; Ammar M Jumaa; Hagir M Elbashir; Mubarak S Karsany
Journal:  Virol J       Date:  2010-07-13       Impact factor: 4.099

3.  Dengue Fever (DF) in Pakistan.

Authors:  Fridous Jahan
Journal:  Asia Pac Fam Med       Date:  2011-02-24

4.  Cross-sectional community-based study of the socio-demographic factors associated with the prevalence of dengue in the eastern part of Sudan in 2011.

Authors:  Mohammed A Soghaier; Sayed Himatt; Kamal ElDin Osman; Somia I Okoued; Osama E Seidahmed; Mark E Beatty; Khalifa Elmusharaf; Jeahan Khogali; Nijood H Shingrai; Mutasim M Elmangory
Journal:  BMC Public Health       Date:  2015-06-18       Impact factor: 3.295

5.  Clinical Profiles of Dengue Infection during an Outbreak in Northern India.

Authors:  Anish Laul; Poonam Laul; Vamsi Merugumala; Ravi Pathak; Urvashi Miglani; Pinkee Saxena
Journal:  J Trop Med       Date:  2016-11-29

6.  Dengue: profile of hematological and biochemical dynamics.

Authors:  Francisca Raimunda F Guerreiro Azin; Romelia Pinheiro Gonçalves; Maria Helena da Silva Pitombeira; Danielle Malta Lima; Ivo Castelo Branco
Journal:  Rev Bras Hematol Hemoter       Date:  2012

7.  Seroprevalence of acute dengue in a Malaysian tertiary medical centre.

Authors:  Chuan Hun Ding; Zetti Zainol Rashid; Md Mostafizur Rahman; NanFeng Khang; Wan Ngor Low; Nurabrar Hussin; Melissa Iqlima Marzuki; Alyaa Nadhira Jaafar; Nurul Ain' Nabilla Roslan; Terukumar Chandrasekaran
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

8.  Detection and serotyping of dengue viruses in febrile patients consulting at the New-Bell District Hospital in Douala, Cameroon.

Authors:  Francine Berlange Sado Yousseu; Fredy Brice Simo Nemg; Sandra Ateutchia Ngouanet; Franck Martin Obam Mekanda; Maurice Demanou
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.